Gestovo 200mg Tablet SR contains Progesterone, a naturally occurring steroid hormone essential for regulating the menstrual cycle and maintaining pregnancy. This sustained-release formulation ensures a steady release of progesterone, optimizing therapeutic efficacy and improving patient compliance. Gestovo is primarily indicated for the treatment of progesterone deficiency, luteal phase support in assisted reproductive technology (ART) protocols, and management of menstrual disorders such as amenorrhea or abnormal uterine bleeding. Additionally, it is utilized in hormone replacement therapy (HRT) to counterbalance estrogen effects and reduce the risk of endometrial hyperplasia in postmenopausal women. Progesterone acts by preparing the endometrium for implantation and maintaining pregnancy by modulating the immune response and inhibiting uterine contractions. The sustained-release mechanism allows for once-daily dosing, minimizing fluctuations in hormone levels and reducing side effects. Common adverse effects may include headache, breast tenderness, dizziness, and gastrointestinal disturbances. Contraindications include known hypersensitivity to progesterone, active thromboembolic disorders, and certain hormone-sensitive cancers. Gestovo should be used under medical supervision with appropriate monitoring. It is essential to follow prescribed dosages and inform healthcare providers of any concurrent medications or medical conditions to avoid potential interactions and ensure safe, effective therapy.